Analyst Profile

Followed by 116 followers
.
Jami Rubin

Jami Rubin

Goldman Sachs
Wall Street Analyst
#1,549 out of 8,087 Wall Street Analysts
#3,181 out of 24,283 experts

Success Rate

62%
49 out of 79 transactions made a profit

Average Return

+9.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Jami Rubin's trades since 2010 and holding each position for 1 Year would result in 62.03% of your transactions generating a profit, with an average return of 9.0% per rating.

Stock Rating Distribution

137Ratings
51.09% Buy
34.31% Hold
14.60% Sell
Distribution of Jami Rubin's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Forest Laboratories
(~FRX)
Rating:Buy
Date:Jun 21, 2013 - Feb 19, 2014
Return:+130.10%
The most profitable rating made by Jami Rubin

Jami Rubin's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Abbott Labs
Jun 07, 2010
Hold
Downgraded
$59.00
(-43.19% Downside)
1Ratings
0.00%
HSP
Hospira Inc
Jun 28, 2013
Sell
Reiterated
1Ratings
0%
-32.80%
SOGCQ
Sabine Oil & Gas
Dec 03, 2013
Sell
Reiterated
1Ratings
100%
+85.00%
~FRX
Forest Labs
Feb 19, 2014
Hold
Downgraded
3Ratings
100%
+98.30%
BXLT
Baxalta Incorporated
Jul 02, 2015
Hold
Initiated
1Ratings
0.00%
Jazz Pharmaceuticals
Sep 27, 2016
Buy
Reiterated
$187.00
(24.72% Upside)
1Ratings
100%
+18.40%
PTLA
Portola Pharma
Jan 09, 2017
Hold
Reiterated
1Ratings
0.00%
Bristol Myers
Feb 09, 2017
Buy
Reiterated
10Ratings
90%
+24.24%
AGN
Allergan
May 10, 2017
Hold
Downgraded
12Ratings
88%
+15.11%
Zoetis
Aug 07, 2017
Hold
Assigned
$62.00
(-59.49% Downside)
3Ratings
0%
-19.90%
List of latest recommendations made by Jami Rubin. Click to expand and see Jami Rubin's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >